1
|
Yang B, Mai TD, Tran NT, Taverna M. In capillary labeling and online electrophoretic separation of N-glycans from glycoproteins. J Sep Sci 2022; 45:3594-3603. [PMID: 35820058 PMCID: PMC9796131 DOI: 10.1002/jssc.202200340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2022] [Revised: 06/16/2022] [Accepted: 07/07/2022] [Indexed: 01/01/2023]
Abstract
In this study, we present a new approach for in-capillary fluorescent labeling of N-glycans prior to their analysis with CE coupled with laser-induced fluorescent detection. This integrated approach allows using a CE capillary as a microreactor to perform several steps required for labeling glycans with 8-aminopyrene-1,3,6 trisulfonic acid and at the same time as a separation channel for CE of fluorescently labeled glycans. This could be achieved through careful optimization of all different steps, including sequential injections of fluorescent dye and glycan plugs, mixing by transverse diffusion of laminar flow profiles, incubation in a thermostatic zone, and finally separation and detection with CE. Such a complex sample treatment protocol for glycan labeling that is feasible thus far only in batchwise mode can now be converted into an automated and integrated protocol. Our approach was applied successfully to analyze fluorescently labeled N-linked oligosaccharides released from human immunoglobulin G and rituximab, a monoclonal antibody used for cancer treatment. We demonstrated the superiority of this in-capillary approach over the conventional in-tube protocol, with fourfold less reagent consumption and full automation without remarkable degradation of the glycan separation profile obtained by capillary electrophoresis.
Collapse
Affiliation(s)
- Bin Yang
- Université Paris‐Saclay, CNRS, Faculté de PharmacieInstitut Galien Paris‐SaclayBâtiment Henri Moissan, 17 Avenue des SciencesOrsay91400France
| | - Thanh Duc Mai
- Université Paris‐Saclay, CNRS, Faculté de PharmacieInstitut Galien Paris‐SaclayBâtiment Henri Moissan, 17 Avenue des SciencesOrsay91400France
| | - Nguyet Thuy Tran
- Université Paris‐Saclay, CNRS, Faculté de PharmacieInstitut Galien Paris‐SaclayBâtiment Henri Moissan, 17 Avenue des SciencesOrsay91400France
| | - Myriam Taverna
- Université Paris‐Saclay, CNRS, Faculté de PharmacieInstitut Galien Paris‐SaclayBâtiment Henri Moissan, 17 Avenue des SciencesOrsay91400France,Institut Universitaire de France (IUF)ParisFrance
| |
Collapse
|
2
|
Kinoshita M, Nakajima K, Yamamoto S, Suzuki S. High-throughput N-glycan screening method for therapeutic antibodies using a microchip-based DNA analyzer: a promising methodology for monitoring monoclonal antibody N-glycosylation. Anal Bioanal Chem 2021; 413:4727-4738. [PMID: 34080034 DOI: 10.1007/s00216-021-03434-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2021] [Revised: 05/11/2021] [Accepted: 05/25/2021] [Indexed: 10/21/2022]
Abstract
N-Glycosylation of therapeutic antibodies is a critical quality attribute (CQA), and the micro-heterogeneity affects the biological and physicochemical properties of antibodies. Therefore, the profiling of N-glycans on antibodies is essential for controlling the manufacturing process and ensuring the efficacy and safety of the therapeutic antibodies. To monitor N-glycosylation in recombinant proteins, a high-throughput (HTP) methodology for glycan analysis is required to handle bulk samples in various stages of the manufacturing process. In this study, we focused on the HTP methodology for N-glycan analysis using a commercial microchip electrophoresis-based DNA analyzer and demonstrated the feasibility of the workflow consisting of sample preparation and electrophoretic separation. Even if there is a demand to analyze up to 96 samples, the present workflow can be completed in a day without expensive instruments and reagent kits for sample preparation, and it will be a promising methodology for cost-effective and facile HTP N-glycosylation analysis while optimizing the manufacturing process and development for therapeutic antibodies.
Collapse
Affiliation(s)
- Mitsuhiro Kinoshita
- Department of Pharmaceutical Sciences, Kindai University, Kowakae 3-4-1, Higashi-osaka, 577-8502, Japan.
| | - Kazuki Nakajima
- Center for Joint Research Facilities Support, Research Promotion and Support Headquarters, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan
| | - Sachio Yamamoto
- Department of Pharmaceutical Sciences, Kindai University, Kowakae 3-4-1, Higashi-osaka, 577-8502, Japan
| | - Shigeo Suzuki
- Department of Pharmaceutical Sciences, Kindai University, Kowakae 3-4-1, Higashi-osaka, 577-8502, Japan
| |
Collapse
|
3
|
Cajic S, Hennig R, Burock R, Rapp E. Capillary (Gel) Electrophoresis-Based Methods for Immunoglobulin (G) Glycosylation Analysis. EXPERIENTIA SUPPLEMENTUM (2012) 2021; 112:137-172. [PMID: 34687009 DOI: 10.1007/978-3-030-76912-3_4] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
The in-depth characterization of protein glycosylation has become indispensable in many research fields and in the biopharmaceutical industry. Especially knowledge about modulations in immunoglobulin G (IgG) N-glycosylation and their effect on immunity enabled a better understanding of human diseases and the development of new, more effective drugs for their treatment. This chapter provides a deeper insight into capillary (gel) electrophoresis-based (C(G)E) glycan analysis, addressing its impressive performance and possibilities, its great potential regarding real high-throughput for large cohort studies, as well as its challenges and limitations. We focus on the latest developments with respect to miniaturization and mass spectrometry coupling, as well as data analysis and interpretation. The use of exoglycosidase sequencing in combination with current C(G)E technology is discussed, highlighting possible difficulties and pitfalls. The application section describes the detailed characterization of N-glycosylation, utilizing multiplexed CGE with laser-induced fluorescence detection (xCGE-LIF). Besides a comprehensive overview on antibody glycosylation by comparing species-specific IgGs and human immunoglobulins A, D, E, G, and M, the chapter comprises a comparison of therapeutic monoclonal antibodies from different production cell lines, as well as a detailed characterization of Fab and Fc glycosylation. These examples illustrate the full potential of C(G)E, resolving the smallest differences in sugar composition and structure.
Collapse
Affiliation(s)
- Samanta Cajic
- Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany
| | - René Hennig
- Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany.
- glyXera GmbH, Magdeburg, Germany.
| | | | - Erdmann Rapp
- Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany
- glyXera GmbH, Magdeburg, Germany
| |
Collapse
|
4
|
Trabik YA, Moenes EM, Al-Ghobashy MA, Nebsen M, Ayad MF. Analytical comparability study of anti-CD20 monoclonal antibodies rituximab and obinutuzumab using a stability-indicating orthogonal testing protocol: Effect of structural optimization and glycoengineering. J Chromatogr B Analyt Technol Biomed Life Sci 2020; 1159:122359. [PMID: 32920338 DOI: 10.1016/j.jchromb.2020.122359] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2020] [Revised: 08/14/2020] [Accepted: 08/29/2020] [Indexed: 01/01/2023]
Abstract
Glycoengineering and biosimilarity are the key factors for growing, promising and progressive approaches in monoclonal antibodies development. In this study, the physicochemical stability of anti-CD20 rituximab (RTX); originator and biosimilar was compared to its glycoengineered humanized version; obinutuzumab (OBZ). An orthogonal stability-indicating protocol using a set of validated bioanalytical techniques; size exclusion high performance liquid chromatography (SE-HPLC), reversed phase liquid chromatography (RP-HPLC), quantitative gel electrophoresis by TapeStation, receptor binding assay and dynamic light scattering (DLS) was used to investigate the effect of different stress factors on the pattern and kinetics of degradation. SE-HPLC results supported with spectral purity showed similar degradation extent with a different pattern of degradation between RTX and OBZ. A lower tendency to form degraded fragments and a relatively higher favorability for degradation through aggregate formation has been revealed in case of OBZ. Results were in agreement with those of DLS and receptor binding assay which showed specificity to the intact antibodies in the presence of their degradation products. Furthermore, results were additionally confirmed through denaturing quantitative gel electrophoresis which suggested reducible covalent bonds as the mechanism for aggregates formation. RP-HPLC results showed two oxidized forms via excessive oxidation of RTX and OBZ with nearly the same degradation percent. Comparability data of RTX and OBZ using the applied methodologies showed that although glycoengineering; carried out to enhance the therapeutic and biological activity of OBZ altered the pattern of degradation but did not significantly affect the overall stability. Results showed also consistent stability profile between the biosimilar and its originator RTX products.
Collapse
Affiliation(s)
- Yossra A Trabik
- Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Egypt
| | - Eman M Moenes
- National Organization for Research and Control of Biologicals, Egypt
| | - Medhat A Al-Ghobashy
- Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Egypt; Bioanalysis Research Group, School of Pharmacy, Newgiza University, Egypt.
| | - Marianne Nebsen
- Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Egypt
| | - Miriam F Ayad
- Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Egypt
| |
Collapse
|
5
|
Chen Y, Barreto V, Woodruff A, Lu Z, Liu Y, Pohl C. Dual Electrolytic Eluent Generation for Oligosaccharides Analysis Using High-Performance Anion-Exchange Chromatography. Anal Chem 2018; 90:10910-10916. [DOI: 10.1021/acs.analchem.8b02436] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Yongjing Chen
- Thermo Fisher Scientific, 1228 Titan Way, Sunnyvale, California 94088-3603, United States
| | - Victor Barreto
- Thermo Fisher Scientific, 1228 Titan Way, Sunnyvale, California 94088-3603, United States
| | - Andy Woodruff
- Thermo Fisher Scientific, 1228 Titan Way, Sunnyvale, California 94088-3603, United States
| | - Zhongqing Lu
- Thermo Fisher Scientific, 1228 Titan Way, Sunnyvale, California 94088-3603, United States
| | - Yan Liu
- Thermo Fisher Scientific, 1228 Titan Way, Sunnyvale, California 94088-3603, United States
| | - Christopher Pohl
- Thermo Fisher Scientific, 1228 Titan Way, Sunnyvale, California 94088-3603, United States
| |
Collapse
|
6
|
Profiling of N-linked glycans from 100 cells by capillary electrophoresis with large-volume dual preconcentration by isotachophoresis and stacking. J Chromatogr A 2018; 1565:138-144. [DOI: 10.1016/j.chroma.2018.06.034] [Citation(s) in RCA: 39] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2018] [Revised: 06/06/2018] [Accepted: 06/14/2018] [Indexed: 01/19/2023]
|
7
|
Bennett LD, Yang Q, Berquist BR, Giddens JP, Ren Z, Kommineni V, Murray RP, White EL, Holtz BR, Wang LX, Marcel S. Implementation of Glycan Remodeling to Plant-Made Therapeutic Antibodies. Int J Mol Sci 2018; 19:E421. [PMID: 29385073 PMCID: PMC5855643 DOI: 10.3390/ijms19020421] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2017] [Revised: 01/09/2018] [Accepted: 01/27/2018] [Indexed: 11/16/2022] Open
Abstract
N-glycosylation profoundly affects the biological stability and function of therapeutic proteins, which explains the recent interest in glycoengineering technologies as methods to develop biobetter therapeutics. In current manufacturing processes, N-glycosylation is host-specific and remains difficult to control in a production environment that changes with scale and production batches leading to glycosylation heterogeneity and inconsistency. On the other hand, in vitro chemoenzymatic glycan remodeling has been successful in producing homogeneous pre-defined protein glycoforms, but needs to be combined with a cost-effective and scalable production method. An efficient chemoenzymatic glycan remodeling technology using a plant expression system that combines in vivo deglycosylation with an in vitro chemoenzymatic glycosylation is described. Using the monoclonal antibody rituximab as a model therapeutic protein, a uniform Gal2GlcNAc2Man3GlcNAc2 (A2G2) glycoform without α-1,6-fucose, plant-specific α-1,3-fucose or β-1,2-xylose residues was produced. When compared with the innovator product Rituxan®, the plant-made remodeled afucosylated antibody showed similar binding affinity to the CD20 antigen but significantly enhanced cell cytotoxicity in vitro. Using a scalable plant expression system and reducing the in vitro deglycosylation burden creates the potential to eliminate glycan heterogeneity and provide affordable customization of therapeutics' glycosylation for maximal and targeted biological activity. This feature can reduce cost and provide an affordable platform to manufacture biobetter antibodies.
Collapse
Affiliation(s)
- Lindsay D Bennett
- Metropolitan Nashville Police Department Crime Lab, 400 Myatt Drive, Madison, TN 37115, USA.
| | - Qiang Yang
- Department of Chemistry and Biochemistry, University of Maryland, 8051 Regents Drive, College Park, MD 20742, USA.
| | - Brian R Berquist
- iBio CDMO, 8800 Health Science Center Parkway, Bryan, TX 77807, USA.
| | - John P Giddens
- Department of Chemistry and Biochemistry, University of Maryland, 8051 Regents Drive, College Park, MD 20742, USA.
| | - Zhongjie Ren
- iBio CDMO, 8800 Health Science Center Parkway, Bryan, TX 77807, USA.
| | - Vally Kommineni
- iBio CDMO, 8800 Health Science Center Parkway, Bryan, TX 77807, USA.
| | - Ryan P Murray
- Lonza Houston, Inc., 8066 El Rio St., Houston, TX 77054, USA.
| | - Earl L White
- MDx BioAnalytical Laboratory, Inc., 5890 Imperial loop, Suite 12, College Station, TX 77845, USA.
| | - Barry R Holtz
- iBio CDMO, 8800 Health Science Center Parkway, Bryan, TX 77807, USA.
| | - Lai-Xi Wang
- Department of Chemistry and Biochemistry, University of Maryland, 8051 Regents Drive, College Park, MD 20742, USA.
| | - Sylvain Marcel
- iBio CDMO, 8800 Health Science Center Parkway, Bryan, TX 77807, USA.
| |
Collapse
|
8
|
Parekh BS, Srivastava A, Sundaram S, Ching-Heish M, Goldstein J, Barry M, Zhou Q. Correlating charge heterogeneity data generated by agarose gel isoelectric focusing and ion exchange chromatography methods. J Chromatogr B Analyt Technol Biomed Life Sci 2018; 1073:1-9. [PMID: 29232605 DOI: 10.1016/j.jchromb.2017.11.043] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2017] [Revised: 11/27/2017] [Accepted: 11/30/2017] [Indexed: 10/18/2022]
Abstract
An isoelectric focusing method (IEF) has been used to assess the charge heterogeneity profile of a monoclonal antibody during the early stages of product development. A more precise and sensitive ion exchange chromatography (IEC/CEX) method was developed and implemented as development progressed and was used concurrently with IEF for lot release and to monitor charge heterogeneity. Charge variants resolved by both methods (IEC and IEF) were purified and characterized. Tryptic peptide mapping and N- linked oligosaccharide profile analyses of the IEC and IEF fractions indicated a structural correlation between the charge variants separated by these two methods. The major sources of molecular heterogeneity were due to the variation in the sialyated carbohydrate structure and heavy chain C-terminal lysine truncation. By monitoring the rates of change in the charge heterogeneity profiles of the monoclonal antibody stored at elevated temperatures by the IEC and IEF methods, a positive correlation between the two methods was established. This approach enabled replacement of the IEF method with the more precise IEC method.
Collapse
Affiliation(s)
- Babita Saxena Parekh
- BioAnalytical Sciences, Eli Lilly and Company, Branchburg, NJ 08876, United States
| | - Arvind Srivastava
- BioAnalytical Sciences, Eli Lilly and Company, Branchburg, NJ 08876, United States
| | - Shanmuuga Sundaram
- BioAnalytical Sciences, Eli Lilly and Company, Branchburg, NJ 08876, United States.
| | - Ming Ching-Heish
- BioAnalytical Sciences, Eli Lilly and Company, Branchburg, NJ 08876, United States
| | - Joel Goldstein
- BioAnalytical Sciences, Eli Lilly and Company, Branchburg, NJ 08876, United States
| | - Michael Barry
- BioAnalytical Sciences, Eli Lilly and Company, Branchburg, NJ 08876, United States
| | - Qinwei Zhou
- BioAnalytical Sciences, Eli Lilly and Company, Branchburg, NJ 08876, United States
| |
Collapse
|
9
|
Zhang M, Li G, Zhang Y, Kang J. Quantitative analysis of antithrombin III binding site in low molecular weight heparins by exhausetive heparinases digestion and capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci 2017; 1068-1069:78-83. [PMID: 29031112 DOI: 10.1016/j.jchromb.2017.08.047] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2017] [Revised: 08/12/2017] [Accepted: 08/16/2017] [Indexed: 10/18/2022]
Abstract
The antithrombin III (ATIII)-binding site, which contains a special 3-O-sulfated, N-sulfated glucosamine residue with or without 6-O-sulfation, is mainly responsible for the anticoagulant activity of heparin. Undergoing the chemical depolymerization process, the preservation of the ATIII-binding site in low molecular weight heparins (LMWHs) are varied leading to the fluctuation of the anticoagulant activity. Herein we report a capillary electrophoresis (CE) method in combination with heparinase digestion and affinity chromatography for the measurement of molar percentage of ATIII-binding site of LMWHs. After exhaustively digesting LMWHs with the mixture of heparinase I, II and III, almost all the resulting oligosaccharide building blocks, including the three 3-O-sulfated tetrasaccharides derived from the ATIII-binding site, were resolved by CE separation. The peak area of each building block permits quantification of the molar percentage of the ATIII-binding site. The peaks corresponding to the 3-O-sulfated tetrasaccharides were assigned based on the linear relationship between the electrophoretic mobilities of the oligosaccharides and their charge to mass ratios. The peak assignment was further confirmed by analysis of the high ATIII affinity fractions, which contains much high 3-O-sulfated tetrasaccharides. With the method, the molar percentage of the ATIII-binding site of enoxaparin from different batches and different manufactures were measured and compared. It was demonstrated that the CE method provides more precise data for assessing the anti-FXa activity than that of the biochemical assay method.
Collapse
Affiliation(s)
- Mingyu Zhang
- State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Lingling Road 345, Shanghai 200032, China
| | - Gong Li
- State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Lingling Road 345, Shanghai 200032, China
| | - Yi Zhang
- State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Lingling Road 345, Shanghai 200032, China
| | - Jingwu Kang
- State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Lingling Road 345, Shanghai 200032, China; School of Physical Science and Technology, ShanghaiTech University, Haike Road 100, Shanghai 200031, China.
| |
Collapse
|
10
|
Abstract
Glycosylation is one of the most common and essential protein modifications. Glycans conjugated to biomolecules modulate the function of such molecules through both direct recognition of glycan structures and indirect mechanisms that involve the control of protein turnover rates, stability, and conformation. The biological attributes of glycans in numerous biological processes and implications in a number of diseases highlight the necessity for comprehensive characterization of protein glycosylation. This chapter reviews cutting-edge methods and tools developed to facilitate quantitative glycomics. This chapter highlights the different methods employed for the release and purification of glycans from biological samples. The most effective labeling methods developed for sensitive quantitative glycomics are also described and discussed. The chromatographic approaches that have been used effectively in glycomics are also highlighted.
Collapse
Affiliation(s)
- L Veillon
- Texas Tech University, Lubbock, TX, United States
| | - S Zhou
- Texas Tech University, Lubbock, TX, United States
| | - Y Mechref
- Texas Tech University, Lubbock, TX, United States.
| |
Collapse
|
11
|
Mitra I, Snyder CM, Zhou X, Campos MI, Alley WR, Novotny MV, Jacobson SC. Structural Characterization of Serum N-Glycans by Methylamidation, Fluorescent Labeling, and Analysis by Microchip Electrophoresis. Anal Chem 2016; 88:8965-71. [PMID: 27504786 DOI: 10.1021/acs.analchem.6b00882] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
To characterize the structures of N-glycans derived from human serum, we report a strategy that combines microchip electrophoresis, standard addition, enzymatic digestion, and matrix-assisted laser desorption/ionization-mass spectrometry (MALDI-MS). We compared (i) electrophoretic mobilities of known N-glycans from well-characterized (standard) glycoproteins through standard addition, (ii) the electrophoretic mobilities of N-glycans with their molecular weights determined by MALDI-MS, and (iii) electrophoretic profiles of N-glycans enzymatically treated with fucosidase. The key step to identify the sialylated N-glycans was to quantitatively neutralize the negative charge on both α2,3- and α2,6-linked sialic acids by covalent derivatization with methylamine. Both neutralized and nonsialylated N-glycans from these samples were then reacted with 8-aminopyrene-1,3,6-trisulfonic acid (APTS) to provide a fluorescent label and a triple-negative charge, separated by microchip electrophoresis, and detected by laser-induced fluorescence. The methylamidation step leads to a 24% increase in the peak capacity of the separation and direct correlation of electrophoretic and MALDI-MS results. In total, 37 unique N-glycan structures were assigned to 52 different peaks recorded in the electropherograms of the serum samples. This strategy ensures the needed separation efficiency and detectability, easily resolves linkage and positional glycan isomers, and is highly reproducible.
Collapse
Affiliation(s)
- Indranil Mitra
- Department of Chemistry, Indiana University , Bloomington, Indiana 47405, United States
| | - Christa M Snyder
- Department of Chemistry, Indiana University , Bloomington, Indiana 47405, United States
| | - Xiaomei Zhou
- Department of Chemistry, Indiana University , Bloomington, Indiana 47405, United States
| | - Margit I Campos
- Department of Chemistry, Indiana University , Bloomington, Indiana 47405, United States
| | - William R Alley
- Department of Chemistry, Indiana University , Bloomington, Indiana 47405, United States
| | - Milos V Novotny
- Department of Chemistry, Indiana University , Bloomington, Indiana 47405, United States
| | - Stephen C Jacobson
- Department of Chemistry, Indiana University , Bloomington, Indiana 47405, United States
| |
Collapse
|
12
|
Yang N, Goonatilleke E, Park D, Song T, Fan G, Lebrilla CB. Quantitation of Site-Specific Glycosylation in Manufactured Recombinant Monoclonal Antibody Drugs. Anal Chem 2016; 88:7091-100. [PMID: 27311011 PMCID: PMC4955800 DOI: 10.1021/acs.analchem.6b00963] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
During the development of recombinant monoclonal antibody (rMAb) drugs, glycosylation receives particular focus because changes in the attached glycans can have a significant impact on the antibody effector functions. The vast heterogeneity of structures that exist across glycosylation sites hinders the in-depth analysis of glycan changes specific to an individual protein within a complex mixture. In this study, we established a sensitive and specific method for monitoring site-specific glycosylation in rMAbs using multiple reaction monitoring (MRM) on an ultrahigh-performance liquid chromatography-triple quadrupole MS (UHPLC-QqQ-MS). Our results showed that irrespective of the IgG subclass expressed in the drugs, the N-glycopeptide profiles are nearly the same but differ in abundances. In all rMAb drugs, a single subclass of IgG comprised over 97% of the total IgG content and showed over 97% N-glycan site occupancy. This study demonstrates the utility of an MRM-based method to rapidly characterize over 130 distinct glycopeptides and determine the extent of site occupancy within minutes. Such multilevel structural characterization is important for the successful development of therapeutic antibodies.
Collapse
Affiliation(s)
- Nan Yang
- School of Pharmacy, Second Military Medical University, Guohe Road, Shanghai, 200433, China
- Department of Pharmacy, Shanghai General Hospital, Haining Road, Shanghai, 200080, China
| | - Elisha Goonatilleke
- Department of Chemistry, University of California, Davis, One Shields Avenue, Davis, CA 95616, United States
| | - Dayoung Park
- Department of Chemistry, University of California, Davis, One Shields Avenue, Davis, CA 95616, United States
| | - Ting Song
- Department of Chemistry, University of California, Davis, One Shields Avenue, Davis, CA 95616, United States
| | - Guorong Fan
- School of Pharmacy, Second Military Medical University, Guohe Road, Shanghai, 200433, China
- Department of Pharmacy, Shanghai General Hospital, Haining Road, Shanghai, 200080, China
| | - Carlito B. Lebrilla
- Department of Chemistry, University of California, Davis, One Shields Avenue, Davis, CA 95616, United States
| |
Collapse
|
13
|
Zhang L, Luo S, Zhang B. Glycan analysis of therapeutic glycoproteins. MAbs 2015; 8:205-15. [PMID: 26599345 PMCID: PMC4966609 DOI: 10.1080/19420862.2015.1117719] [Citation(s) in RCA: 126] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2015] [Revised: 10/26/2015] [Accepted: 11/02/2015] [Indexed: 01/02/2023] Open
Abstract
Therapeutic monoclonal antibodies (mAbs) are glycoproteins produced by living cell systems. The glycan moieties attached to the proteins can directly affect protein stability, bioactivity, and immunogenicity. Therefore, glycan variants of a glycoprotein product must be adequately analyzed and controlled to ensure product quality. However, the inherent complexity of protein glycosylation poses a daunting analytical challenge. This review provides an update of recent advances in glycan analysis, including the potential utility of lectin-based microarray for high throughput glycan profiling. Emphasis is placed on comparison of the major types of analytics for use in determining unique glycan features such as glycosylation site, glycan structure, and content.
Collapse
Affiliation(s)
- Lei Zhang
- Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland
| | - Shen Luo
- Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland
| | - Baolin Zhang
- Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland
| |
Collapse
|
14
|
Alinat E, Delaunay N, Przybylski C, Daniel R, Archer X, Gareil P. Capillary electrophoresis fingerprinting of 8-aminopyrene-1,3,6-trisulfonate derivatized nitrocellulose after partial acid depolymerization. J Chromatogr A 2015; 1387:134-43. [DOI: 10.1016/j.chroma.2015.01.092] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2014] [Revised: 01/23/2015] [Accepted: 01/29/2015] [Indexed: 10/24/2022]
|
15
|
Tamizi E, Jouyban A. The potential of the capillary electrophoresis techniques for quality control of biopharmaceuticals-A review. Electrophoresis 2015; 36:831-58. [DOI: 10.1002/elps.201400343] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2014] [Revised: 11/27/2014] [Accepted: 11/27/2014] [Indexed: 12/24/2022]
Affiliation(s)
- Elnaz Tamizi
- Biotechnology Research Center; Tabriz University of Medical Sciences; Tabriz Iran
| | - Abolghasem Jouyban
- Pharmacy Faculty and Drug Applied Research Center; Tabriz University of Medical Sciences; Tabriz Iran
| |
Collapse
|
16
|
Ponniah G, Nowak C, Gonzalez N, Miano D, Liu H. Detection and Quantitation of Low Abundance Oligosaccharides in Recombinant Monoclonal Antibodies. Anal Chem 2015; 87:2718-26. [DOI: 10.1021/ac504738c] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- Gomathinayagam Ponniah
- Product
Characterization, Alexion Pharmaceuticals Inc., 352 Knotter Drive, Cheshire, Connecticut 06410, United States
| | - Christine Nowak
- Product
Characterization, Alexion Pharmaceuticals Inc., 352 Knotter Drive, Cheshire, Connecticut 06410, United States
| | - Nidia Gonzalez
- Product
Characterization, Alexion Pharmaceuticals Inc., 352 Knotter Drive, Cheshire, Connecticut 06410, United States
| | - Dino Miano
- Product
Characterization, Alexion Pharmaceuticals Inc., 352 Knotter Drive, Cheshire, Connecticut 06410, United States
| | - Hongcheng Liu
- Product
Characterization, Alexion Pharmaceuticals Inc., 352 Knotter Drive, Cheshire, Connecticut 06410, United States
| |
Collapse
|
17
|
Wang D, Wynne C, Gu F, Becker C, Zhao J, Mueller HM, Li H, Shameem M, Liu YH. Characterization of Drug-Product-Related Impurities and Variants of a Therapeutic Monoclonal Antibody by Higher Energy C-Trap Dissociation Mass Spectrometry. Anal Chem 2015; 87:914-21. [DOI: 10.1021/ac503158g] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Affiliation(s)
- Deyun Wang
- Eurofins-Lancaster Laboratories Inc., 2425
New Holland Pike, Lancaster, Pennsylvania 17601, United States
| | - Colin Wynne
- Eurofins-Lancaster Laboratories Inc., 2425
New Holland Pike, Lancaster, Pennsylvania 17601, United States
| | - Flora Gu
- Protein
Mass Spectrometry, Sterile Product and Analytical Development, Bioprocess
Development, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States
| | - Chris Becker
- Protein Metrics Inc., 1622 San
Carlos Avenue, Suite C, San Carlos, California 94070, United States
| | - Jia Zhao
- Protein
Mass Spectrometry, Sterile Product and Analytical Development, Bioprocess
Development, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States
| | - Hans-Martin Mueller
- Protein
Mass Spectrometry, Sterile Product and Analytical Development, Bioprocess
Development, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States
| | - Huijuan Li
- Protein
Mass Spectrometry, Sterile Product and Analytical Development, Bioprocess
Development, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States
| | - Mohammed Shameem
- Protein
Mass Spectrometry, Sterile Product and Analytical Development, Bioprocess
Development, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States
| | - Yan-Hui Liu
- Protein
Mass Spectrometry, Sterile Product and Analytical Development, Bioprocess
Development, Merck Research Laboratories, 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States
| |
Collapse
|
18
|
Liu H, Ponniah G, Zhang HM, Nowak C, Neill A, Gonzalez-Lopez N, Patel R, Cheng G, Kita AZ, Andrien B. In vitro and in vivo modifications of recombinant and human IgG antibodies. MAbs 2014; 6:1145-54. [PMID: 25517300 DOI: 10.4161/mabs.29883] [Citation(s) in RCA: 119] [Impact Index Per Article: 11.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022] Open
Abstract
Tremendous knowledge has been gained in the understanding of various modifications of IgG antibodies, driven mainly by the fact that antibodies are one of the most important groups of therapeutic molecules and because of the development of advanced analytical techniques. Recombinant monoclonal antibody (mAb) therapeutics expressed in mammalian cell lines and endogenous IgG molecules secreted by B cells in the human body share some modifications, but each have some unique modifications. Modifications that are common to recombinant mAb and endogenous IgG molecules are considered to pose a lower risk of immunogenicity. On the other hand, modifications that are unique to recombinant mAbs could potentially pose higher risk. The focus of this review is the comparison of frequently observed modifications of recombinant monoclonal antibodies to those of endogenous IgG molecules.
Collapse
Affiliation(s)
- Hongcheng Liu
- a Protein Characterization; Alexion Pharmaceuticals Inc .; Cheshire , CT USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Váradi C, Lew C, Guttman A. Rapid Magnetic Bead Based Sample Preparation for Automated and High Throughput N-Glycan Analysis of Therapeutic Antibodies. Anal Chem 2014; 86:5682-7. [DOI: 10.1021/ac501573g] [Citation(s) in RCA: 82] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- Csaba Váradi
- Horváth
Laboratory of Bioseparation Sciences, University of Debrecen, Nagyerdei krt 98, Elméleti
tömb, 1/111 H-4032, Debrecen, Hungary
| | - Clarence Lew
- Sciex Separations, 2500 S. Kraemer Blvd., Brea, California 92821, United States
| | - András Guttman
- Horváth
Laboratory of Bioseparation Sciences, University of Debrecen, Nagyerdei krt 98, Elméleti
tömb, 1/111 H-4032, Debrecen, Hungary
- Sciex Separations, 2500 S. Kraemer Blvd., Brea, California 92821, United States
- MTA-PE
Translational Glycomics Research Group, University of Pannonia, 10 Egyetem St., Veszprem H-8200, Hungary
| |
Collapse
|
20
|
Shang TQ, Saati A, Toler KN, Mo J, Li H, Matlosz T, Lin X, Schenk J, Ng CK, Duffy T, Porter TJ, Rouse JC. Development and application of a robust N-glycan profiling method for heightened characterization of monoclonal antibodies and related glycoproteins. J Pharm Sci 2014; 103:1967-1978. [PMID: 24840237 DOI: 10.1002/jps.24004] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2014] [Revised: 04/07/2014] [Accepted: 04/17/2014] [Indexed: 01/22/2023]
Abstract
A highly robust hydrophilic interaction liquid chromatography (HILIC) method that involves both fluorescence and mass spectrometric detection was developed for profiling and characterizing enzymatically released and 2-aminobenzamide (2-AB)-derivatized mAb N-glycans. Online HILIC/mass spectrometry (MS) with a quadrupole time-of-flight mass spectrometer provides accurate mass identifications of the separated, 2-AB-labeled N-glycans. The method features a high-resolution, low-shedding HILIC column with acetonitrile and water-based mobile phases containing trifluoroacetic acid (TFA) as a modifier. This column and solvent system ensures the combination of robust chromatographic performance and full compatibility and sensitivity with online MS in addition to the baseline separation of all typical mAb N-glycans. The use of TFA provided distinct advantages over conventional ammonium formate as a mobile phase additive, such as, optimal elution order for sialylated N-glycans, reproducible chromatographic profiles, and matching total ion current chromatograms, as well as minimal signal splitting, analyte adduction, and fragmentation during HILIC/MS, maximizing sensitivity for trace-level species. The robustness and selectivity of HILIC for N-glycan analyses allowed for method qualification. The method is suitable for bioprocess development activities, heightened characterization, and clinical drug substance release. Application of this HILIC/MS method to the detailed characterization of a marketed therapeutic mAb, Rituxan(®), is described.
Collapse
Affiliation(s)
- Tanya Q Shang
- Analytical Research and Development, Biotherapeutics Pharmaceutical SciencesPfizer, Inc.AndoverMassachusetts 01810
| | - Andrew Saati
- Analytical Research and Development, Biotherapeutics Pharmaceutical SciencesPfizer, Inc.AndoverMassachusetts 01810
| | - Kelly N Toler
- Genzyme, A Sanofi Company, FraminghamMassachusetts01701
| | - Jianming Mo
- Analytical R&D, Pfizer, Inc.St. LouisMissouri63017
| | - Heyi Li
- Analytical R&D, Pfizer, Inc., Pearl RiverNew York10965
| | - Tonya Matlosz
- Analytical R&D, Pfizer, Inc., Pearl RiverNew York10965
| | - Xi Lin
- Analytical R&D, Pfizer, Inc., Pearl RiverNew York10965
| | - Jennifer Schenk
- Analytical Research and Development, Biotherapeutics Pharmaceutical SciencesPfizer, Inc.AndoverMassachusetts 01810
| | - Chee-Keng Ng
- Analytical Research and Development, Biotherapeutics Pharmaceutical SciencesPfizer, Inc.AndoverMassachusetts 01810
| | - Toni Duffy
- Analytical Research and Development, Biotherapeutics Pharmaceutical SciencesPfizer, Inc.AndoverMassachusetts 01810
| | - Thomas J Porter
- Analytical Research and Development, Biotherapeutics Pharmaceutical SciencesPfizer, Inc.AndoverMassachusetts 01810
| | - Jason C Rouse
- Analytical Research and Development, Biotherapeutics Pharmaceutical SciencesPfizer, Inc.AndoverMassachusetts 01810.
| |
Collapse
|
21
|
Nebija D, Noe CR, Urban E, Lachmann B. Quality control and stability studies with the monoclonal antibody, trastuzumab: application of 1D- vs. 2D-gel electrophoresis. Int J Mol Sci 2014; 15:6399-411. [PMID: 24739811 PMCID: PMC4013636 DOI: 10.3390/ijms15046399] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2013] [Revised: 03/10/2014] [Accepted: 03/31/2014] [Indexed: 12/05/2022] Open
Abstract
Recombinant monoclonal antibodies (rmAbs) are medicinal products obtained by rDNA technology. Consequently, like other biopharmaceuticals, they require the extensive and rigorous characterization of the quality attributes, such as identity, structural integrity, purity and stability. The aim of this work was to study the suitability of gel electrophoresis for the assessment of charge heterogeneity, post-translational modifications and the stability of the therapeutic, recombinant monoclonal antibody, trastuzumab. One-dimensional, SDS-PAGE, under reducing and non-reducing conditions, and two-dimensional gel electrophoresis were used for the determination of molecular mass (Mr), the isoelectric point (pI), charge-related isoform patterns and the stability of trastuzumab, subjected to stressed degradation and long-term conditions. For the assessment of the influence of glycosylation in the charge heterogeneity pattern of trastuzumab, an enzymatic deglycosylation study has been performed using N-glycosidase F and sialidase, whereas carboxypeptidase B was used for the lysine truncation study. Experimental data documented that 1D and 2D gel electrophoresis represent fast and easy methods to evaluate the quality of biological medicinal products. Important stability parameters, such as the protein aggregation, can be assessed, as well.
Collapse
Affiliation(s)
- Dashnor Nebija
- Department of Pharmaceutical Chemistry, Medical Faculty, Rr. Bulevardi i Deshmoreve, n.n. 10000 Pristina, Kosovo.
| | - Christian R Noe
- Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.
| | - Ernst Urban
- Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.
| | - Bodo Lachmann
- Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria.
| |
Collapse
|
22
|
Adamczyk B, Tharmalingam-Jaikaran T, Schomberg M, Szekrényes Á, Kelly RM, Karlsson NG, Guttman A, Rudd PM. Comparison of separation techniques for the elucidation of IgG N-glycans pooled from healthy mammalian species. Carbohydr Res 2014; 389:174-85. [PMID: 24680513 DOI: 10.1016/j.carres.2014.01.018] [Citation(s) in RCA: 57] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2013] [Revised: 01/13/2014] [Accepted: 01/23/2014] [Indexed: 12/25/2022]
Abstract
The IgG N-glycome provides sufficient complexity and information content to serve as an excellent source for biomarker discovery in mammalian health. Since oligosaccharides play a significant role in many biological processes it is very important to understand their structure. The glycosylation is cell type specific as well as highly variable depending on the species producing the IgG. We evaluated the variation of N-linked glycosylation of human, bovine, ovine, equine, canine and feline IgG using three orthogonal glycan separation techniques: hydrophilic interaction liquid chromatography (HILIC)-UPLC, reversed phase (RP)-UPLC and capillary electrophoresis with laser induced fluorescence detection (CE-LIF). The separation of the glycans by these high resolution methods yielded different profiles due to diverse chemistries. However, the % abundance of structures obtained by CE-LIF and HILIC-UPLC were similar, whereas the analysis by RP-UPLC was difficult to compare as the structures were separated by classes of glycans (highly mannosylated, fucosylated, bisected, fucosylated and bisected) resulting in the co-elution of many structures. The IgGs from various species were selected due to the complexity and variation in their N-glycan composition thereby highlighting the complementarity of these separation techniques.
Collapse
Affiliation(s)
- Barbara Adamczyk
- GlycoScience Group, NIBRT-The National Institute for Bioprocessing Research and Training, Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland; Medical Biochemistry, University of Gothenburg, Gothenburg, Sweden
| | - Tharmala Tharmalingam-Jaikaran
- GlycoScience Group, NIBRT-The National Institute for Bioprocessing Research and Training, Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland
| | - Michael Schomberg
- GlycoScience Group, NIBRT-The National Institute for Bioprocessing Research and Training, Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland
| | - Ákos Szekrényes
- Horváth Laboratory for Bioseparation Sciences, Research Center for Molecular Medicine, University of Debrecen, 4032 Debrecen, Hungary
| | - Ronan M Kelly
- GlycoScience Group, NIBRT-The National Institute for Bioprocessing Research and Training, Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland
| | | | - Andràs Guttman
- Horváth Laboratory for Bioseparation Sciences, Research Center for Molecular Medicine, University of Debrecen, 4032 Debrecen, Hungary; MTA-TKI Translational Glycomics Research Group, University of Pannonia, Veszprem, Hungary
| | - Pauline M Rudd
- GlycoScience Group, NIBRT-The National Institute for Bioprocessing Research and Training, Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland.
| |
Collapse
|
23
|
Bunz SC, Rapp E, Neusüss C. Capillary electrophoresis/mass spectrometry of APTS-labeled glycans for the identification of unknown glycan species in capillary electrophoresis/laser-induced fluorescence systems. Anal Chem 2013; 85:10218-24. [PMID: 24024676 DOI: 10.1021/ac401930j] [Citation(s) in RCA: 62] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
The examination of protein glycosylation is of high importance, especially in the (bio)pharmaceutical sector. The analysis of protein glycosylation is conducted routinely in high performance by capillary electrophoresis with laser-induced fluorescence (CE/LIF) using 8-aminopyrene-1,3,6-trisulfonic acid (APTS)-labeled glycans. In this work we present an optimized capillary electrophoresis/time-of-flight mass spectrometry (CE/TOF-MS) methodology for these labeled glycans, which combines the high separation performance of CE with the high resolution, accuracy, and speed of TOF-MS for eased glycan identification. The system based on an acidic background electrolyte (BGE) provides a migration direction analogue to routine CE/LIF systems. Different BGE compositions, capillary dimensions, coatings, and instrumental parameters were tested to optimize the system with respect to separation efficiency and robustness. Subsequently, the CE/MS method optimized for acidic conditions was compared to an alkaline CE/MS method. Further, the mobilities of six APTS-labeled complex-type N-glycans were compared for both CE/MS methods and two standard CE/LIF approaches. For the acidic and alkaline BGE systems, the mobilities of sialylated glycans were shifted relative to nonsialylated glycans in comparison to common CE/LIF systems. However, in this study a straightforward unequivocal peak assignment was achieved for all unknown glycans in a medium complex glycan mixture from a fusion protein.
Collapse
|
24
|
Wang Y, Santos M, Guttman A. Comparative core fucosylation analysis of some major therapeutic antibody N-glycans by direct infusion ESI-MS and CE-LIF detection. J Sep Sci 2013; 36:2862-7. [PMID: 23801428 DOI: 10.1002/jssc.201300528] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2013] [Revised: 06/12/2013] [Accepted: 06/13/2013] [Indexed: 12/20/2022]
Abstract
The analysis of carbohydrate moieties of glycoprotein biopharmaceuticals is of high importance, especially because glycosylation changes can impact the biological effect of the drugs. In the case of monoclonal antibody therapeutics, the degree of core fucosylation significantly influences its effector function, thus should be closely monitored during the clone selection, development and manufacturing processes. MS analysis of labile sugar residues such as core fucosylation and terminal silylation may be misleading as such residues can break off during the ionization process or alter the ionization efficiency, both of which affect the results. In the case of monoclonal antibody therapeutics tailored for antibody-dependent cellular cytotoxicity function, core fucosylation should be kept minimal; therefore, close attention should be paid to the prevalence of this particular sugar residue. This paper reports on the core fucosylation analysis of some major immunoglobulin G N-glycans by direct infusion ESI-MS and CE-LIF. In comparison to the industry standard of CE-LIF, a lower degree of core fucosylated structures was found by ESI-MS analysis, emphasizing the need to use orthogonal quantitative separation methods in addition to MS.
Collapse
Affiliation(s)
- Yueju Wang
- Department of Chemical Physiology and Cell Biology, The Scripps Research Institute, La Jolla, CA, USA
| | | | | |
Collapse
|
25
|
Guttman A. Capillary electrophoresis in the N-glycosylation analysis of biopharmaceuticals. Trends Analyt Chem 2013. [DOI: 10.1016/j.trac.2013.04.006] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
26
|
Mittermayr S, Bones J, Guttman A. Unraveling the Glyco-Puzzle: Glycan Structure Identification by Capillary Electrophoresis. Anal Chem 2013; 85:4228-38. [DOI: 10.1021/ac4006099] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Stefan Mittermayr
- Horváth
Laboratory of
Bioseparation Sciences, Regional Center for Molecular Medicine, University of Debrecen, Debrecen, Hungary
| | - Jonathan Bones
- NIBRT−The National Institute for Bioprocessing Research and Training, Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland
| | - András Guttman
- Horváth
Laboratory of
Bioseparation Sciences, Regional Center for Molecular Medicine, University of Debrecen, Debrecen, Hungary
- MTA-PE Translational Glycomics
Group, University of Pannonia, Veszprem,
Hungary
| |
Collapse
|
27
|
Alley WR, Mann BF, Novotny MV. High-sensitivity analytical approaches for the structural characterization of glycoproteins. Chem Rev 2013; 113:2668-732. [PMID: 23531120 PMCID: PMC3992972 DOI: 10.1021/cr3003714] [Citation(s) in RCA: 239] [Impact Index Per Article: 21.7] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Affiliation(s)
- William R. Alley
- Department of Chemistry, Indiana University, Bloomington, Indiana, United States
- National Center for Glycomics and Glycoproteomics, Indiana University, Bloomington, Indiana, United States
| | - Benjamin F. Mann
- Department of Chemistry, Indiana University, Bloomington, Indiana, United States
- National Center for Glycomics and Glycoproteomics, Indiana University, Bloomington, Indiana, United States
| | - Milos V. Novotny
- Department of Chemistry, Indiana University, Bloomington, Indiana, United States
- National Center for Glycomics and Glycoproteomics, Indiana University, Bloomington, Indiana, United States
- Indiana University School of Medicine, Indiana University, Indianapolis, Indiana, United States
| |
Collapse
|
28
|
Hamm M, Wang Y, Rustandi RR. Characterization of N-Linked Glycosylation in a Monoclonal Antibody Produced in NS0 Cells Using Capillary Electrophoresis with Laser-Induced Fluorescence Detection. Pharmaceuticals (Basel) 2013; 6:393-406. [PMID: 24276024 PMCID: PMC3816692 DOI: 10.3390/ph6030393] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2013] [Revised: 02/28/2013] [Accepted: 03/13/2013] [Indexed: 12/19/2022] Open
Abstract
The N-linked glycosylation in recombinant monoclonal antibodies (mAb) occurs at Asn297 on the Fc region in the CH2 domain. Glycosylation heterogeneities have been well documented to affect biological activities such as antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) through their interaction with Fc-receptors. Hence, it is critical to monitor and characterize the N-linked glycosylation profile in a therapeutic protein such as a mAb for product consistency. In one approach, the glycans are first released from the mAb using an enzyme specific digestion, such as Protein N-Glycosidase F (PNGase) and subsequently they are labeled using a fluorophore, for example, 8-aminopyrene-1,3,6-trisulfonic acid (APTS) . Here we have applied this approach and used Capillary Electrophoresis with Laser-Induced Fluorescence detection (CE-LIF) to analyze a recombinant mAb produced in murine myeloma (NS0) cells. The technique provides short analysis times, efficient separations, and high sensitivity. CE-LIF peak identification was done by a combination of glycan standards and treatment with various exoglycosidases. Furthermore, the APTS-labeled glycans were also analyzed using hydrophilic interaction chromatography (HILIC) high performance liquid chromatography (HPLC) to aid identification of minor peaks by sample collection and off-line mass spectrometry (MS) analysis.
Collapse
Affiliation(s)
- Melissa Hamm
- Vaccine Analytical Development, Merck Research Laboratories, West Point, PA 19486, USA.
| | | | | |
Collapse
|
29
|
Novotny MV, Alley WR, Mann BF. Analytical glycobiology at high sensitivity: current approaches and directions. Glycoconj J 2013; 30:89-117. [PMID: 22945852 PMCID: PMC3586546 DOI: 10.1007/s10719-012-9444-8] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2012] [Revised: 06/29/2012] [Accepted: 08/14/2012] [Indexed: 12/30/2022]
Abstract
This review summarizes the analytical advances made during the last several years in the structural and quantitative determinations of glycoproteins in complex biological mixtures. The main analytical techniques used in the fields of glycomics and glycoproteomics involve different modes of mass spectrometry and their combinations with capillary separation methods such as microcolumn liquid chromatography and capillary electrophoresis. The need for high-sensitivity measurements have been emphasized in the oligosaccharide profiling used in the field of biomarker discovery through MALDI mass spectrometry. High-sensitivity profiling of both glycans and glycopeptides from biological fluids and tissue extracts has been aided significantly through lectin preconcentration and the uses of affinity chromatography.
Collapse
Affiliation(s)
- Milos V Novotny
- Department of Chemistry, Indiana University, Bloomington, IN, USA.
| | | | | |
Collapse
|
30
|
Mechref Y, Hu Y, Desantos-Garcia JL, Hussein A, Tang H. Quantitative glycomics strategies. Mol Cell Proteomics 2013; 12:874-84. [PMID: 23325767 DOI: 10.1074/mcp.r112.026310] [Citation(s) in RCA: 78] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Abstract
The correlations between protein glycosylation and many biological processes and diseases are increasing the demand for quantitative glycomics strategies enabling sensitive monitoring of changes in the abundance and structure of glycans. This is currently attained through multiple strategies employing several analytical techniques such as capillary electrophoresis, liquid chromatography, and mass spectrometry. The detection and quantification of glycans often involve labeling with ionic and/or hydrophobic reagents. This step is needed in order to enhance detection in spectroscopic and mass spectrometric measurements. Recently, labeling with stable isotopic reagents has also been presented as a very viable strategy enabling relative quantitation. The different strategies available for reliable and sensitive quantitative glycomics are herein described and discussed.
Collapse
Affiliation(s)
- Yehia Mechref
- Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409, USA.
| | | | | | | | | |
Collapse
|
31
|
Rustandi RR, Anderson C, Hamm M. Application of capillary electrophoresis in glycoprotein analysis. Methods Mol Biol 2013; 988:181-197. [PMID: 23475720 DOI: 10.1007/978-1-62703-327-5_11] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Capillary electrophoresis (CE) is a versatile analytical method used to characterize glycoproteins. We have used several modes of CE separation such as CE-SDS gel, imaged capillary isoelectric focusing (icIEF), and capillary zone electrophoresis (CZE) to study therapeutic glycoprotein products. CE-SDS gel is applied to characterize the glycan occupancy and number of glycosylation sites, and icIEF is used to study the charge heterogeneities due to sialic acids in glycoproteins. To further characterize the glycoprotein, removal of N-linked glycans is necessary and a CZE technique is employed to analyze each glycan moiety. Examples from a monoclonal antibody, erythropoietin, and granulocyte colony-stimulating factor are presented here to demonstrate the utility of these CE modes. The details of sample preparation and separation conditions for each CE mode are described in this chapter.
Collapse
Affiliation(s)
- Richard R Rustandi
- Vaccine Analytical Development, Merck Research Laboratories, West Point, PA, USA
| | | | | |
Collapse
|
32
|
Yagi Y, Kakehi K, Hayakawa T, Ohyama Y, Suzuki S. Specific detection of N-glycolylneuraminic acid and Galα1–3Gal epitopes of therapeutic antibodies by partial-filling capillary electrophoresis. Anal Biochem 2012; 431:120-6. [DOI: 10.1016/j.ab.2012.09.006] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2012] [Revised: 09/01/2012] [Accepted: 09/04/2012] [Indexed: 10/27/2022]
|
33
|
Du Y, Wang F, May K, Xu W, Liu H. LC–MS analysis of glycopeptides of recombinant monoclonal antibodies by a rapid digestion procedure. J Chromatogr B Analyt Technol Biomed Life Sci 2012; 907:87-93. [DOI: 10.1016/j.jchromb.2012.09.004] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2012] [Revised: 08/28/2012] [Accepted: 09/03/2012] [Indexed: 11/16/2022]
|
34
|
Yin S, Pastuskovas CV, Khawli LA, Stults JT. Characterization of therapeutic monoclonal antibodies reveals differences between in vitro and in vivo time-course studies. Pharm Res 2012; 30:167-78. [PMID: 22956170 DOI: 10.1007/s11095-012-0860-z] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2012] [Accepted: 08/08/2012] [Indexed: 01/18/2023]
Abstract
PURPOSE To examine and determine the sites and the kinetics of IgG1 mAb modifications from both in vitro (rat plasma and PBS) and in vivo (rat model) time-course studies. METHODS A comprehensive set of protein characterization methods, including RPLC/MS, LC-MS/MS, iCIEF, capSEC, and CE-SDS were performed in this report. RESULTS We demonstrate that plasma incubation and in vivo circulation increase the rate of C-terminal lysine removal, and the levels of deamidation, pyroglutamic acid (pyroE), and thioether-linked (lanthionine) heavy chain and light chain (HC-S-LC). In contrast, incubation in PBS shows no C-terminal lysine removal, and slower rates of deamidation, pyroE, and HC-S-LC formation. Other potential modifications such as oxidation, aggregation, and peptide bonds hydrolysis are not enhanced. CONCLUSION This study demonstrates that in vivo mAb modifications are not fully represented by in vitro PBS or plasma incubation. The differences in modifications and their rates reflect the dissimilarities of matrices and the impact of enzymes. These observations provide valuable evidence and knowledge in evaluating the criticality of modifications that occur naturally in vivo that might impact formulation design, therapeutic outcome, and critical quality attribute assessments for therapeutic mAb manufacturing and quality control.
Collapse
Affiliation(s)
- Sheng Yin
- Protein Analytical Chemistry, Genentech, Inc, South San Francisco, California, USA
| | | | | | | |
Collapse
|
35
|
Chung S, Quarmby V, Gao X, Ying Y, Lin L, Reed C, Fong C, Lau W, Qiu ZJ, Shen A, Vanderlaan M, Song A. Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcγ receptor binding and antibody-dependent cell-mediated cytotoxicity activities. MAbs 2012; 4:326-40. [PMID: 22531441 DOI: 10.4161/mabs.19941] [Citation(s) in RCA: 101] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
The presence or absence of core fucose in the Fc region N-linked glycans of antibodies affects their binding affinity toward FcγRIIIa as well as their antibody-dependent cell-mediated cytotoxicity (ADCC) activity. However, the quantitative nature of this structure-function relationship remains unclear. In this study, the in vitro biological activity of an afucosylated anti-CD20 antibody was fully characterized. Further, the effect of fucose reduction on Fc effector functions was quantitatively evaluated using the afucosylated antibody, its "regular" fucosylated counterpart and a series of mixtures containing varying proportions of "regular" and afucosylated materials. Compared with the "regular" fucosylated antibody, the afucosylated antibody demonstrated similar binding interactions with the target antigen (CD20), C1q and FcγRIa, moderate increases in binding to FcγRIIa and IIb, and substantially increased binding to FcγRIIIa. The afucosylated antibodies also showed comparable complement-dependent cytotoxicity activity but markedly increased ADCC activity. Based on EC 50 values derived from dose-response curves, our results indicate that the amount of afucosylated glycan in antibody samples correlate with both FcγRIIIa binding activity and ADCC activity in a linear fashion. Furthermore, the extent of ADCC enhancement due to fucose depletion was not affected by the FcγRIIIa genotype of the effector cells.
Collapse
Affiliation(s)
- Shan Chung
- Department of BioAnalytical Sciences, Genentech, Inc., South San Francisco, CA, USA.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Maeda E, Kita S, Kinoshita M, Urakami K, Hayakawa T, Kakehi K. Analysis of nonhuman N-glycans as the minor constituents in recombinant monoclonal antibody pharmaceuticals. Anal Chem 2012; 84:2373-9. [PMID: 22394092 DOI: 10.1021/ac300234a] [Citation(s) in RCA: 59] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
Minor N-linked glycans containing N-glycolylneuraminic acid residues and/or α-Gal epitopes (i.e., galactose-α1,3-galactose residues) have been reported to be present in recombinant monoclonal antibody (mAb) therapeutics. These contaminations are due to their production processes using nonhuman mammalian cell lines in culture media containing animal-derived materials. In case of the treatment of tumors, we inevitably use such mAbs by careful risk-benefit considerations to prolong patients' lives. However, expanding their clinical applications such as for rheumatism, asthma, and analgesia demands more careful evaluation of the product characteristics. The present work for detailed evaluations of N-glycans demonstrates the methods using capillary electrophoresis with laser-induced fluorescence detection (CE-LIF) and a combination of high-performance liquid chromatography and electrospray ionization time-of-flight mass spectrometry. The CE-LIF method provides excellent separation of both major and minor N-glycans from six commercial mAb pharmaceuticals within 30 min and clearly indicates that a possible trigger of immunogenicity in humans due to the presence of nonhuman N-glycans is present. We strongly believe that the proposed method will be a powerful tool for the analysis of N-glycans of recombinant mAb products in various development stages, such as clone selection, process control, and routine release testing to ensure safety and efficacy of the products.
Collapse
Affiliation(s)
- Eiki Maeda
- Analytical Development Laboratories, CMC Center, Takeda Pharmaceutical Company Limited, Jusohonmachi 2-17-85, Yodogawa-ku, Osaka 532-8686, Japan
| | | | | | | | | | | |
Collapse
|
37
|
Schiel JE, Au J, He HJ, Phinney KW. LC-MS/MS biopharmaceutical glycoanalysis: identification of desirable reference material characteristics. Anal Bioanal Chem 2012; 403:2279-89. [DOI: 10.1007/s00216-012-5749-5] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2011] [Revised: 01/10/2012] [Accepted: 01/13/2012] [Indexed: 01/05/2023]
|
38
|
Cook KS, Bullock K, Sullivan T. Development and qualification of an antibody rapid deglycosylation method. Biologicals 2012; 40:109-17. [PMID: 22257749 DOI: 10.1016/j.biologicals.2011.12.010] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2011] [Revised: 12/13/2011] [Accepted: 12/16/2011] [Indexed: 10/14/2022] Open
Abstract
N-linked glycosylation can influence the biological activity and safety of an antibody as well as be a measure of the consistency of the production process. The released N-glycans is an important part of the development of a therapeutic antibody. The traditional method for N-glycan analysis requires complex and laborious sample preparation and lengthy analysis time. Two preparation steps with limited control are removal of the antibody backbone by ice-cold ethanol precipitation and water removal before 2-AB fluorescent dye labeling. Simplification of the sample preparation and better control of key steps that allows for the characterization/quantitation of glycans during all stages of development of a therapeutic antibody is desired. Recently Prozyme introduced a rapid deglycosylation kit and a rapid tagging kit that address some of these issues. The deglycosylation kit immobilizes the antibody on a membrane, thereby eliminating the precipitation step. An instant fluorescent tag kit eliminates the water removal before the 2-AB labeling step. In addition use of a new chromatography column can improve the glycan resolution and shorten the analysis time. The evaluation and qualification of the Rapid Deglycosylation Kit (RDK) and instant 2-AB tagging with the improved chromatography are highlighted.
Collapse
Affiliation(s)
- K Steven Cook
- Analytical R&D, Pfizer BioTherapeutics R&D Pharmaceutical Sciences, 700 Chesterfield Parkway West, Chesterfield, MO 63017, USA.
| | | | | |
Collapse
|
39
|
Li J, Wong CL, Vijayasankaran N, Hudson T, Amanullah A. Feeding lactate for CHO cell culture processes: Impact on culture metabolism and performance. Biotechnol Bioeng 2011; 109:1173-86. [DOI: 10.1002/bit.24389] [Citation(s) in RCA: 93] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2011] [Revised: 10/18/2011] [Accepted: 11/16/2011] [Indexed: 02/03/2023]
|
40
|
Uçaktürk E. Analysis of glycoforms on the glycosylation site and the glycans in monoclonal antibody biopharmaceuticals. J Sep Sci 2011; 35:341-50. [PMID: 22213703 DOI: 10.1002/jssc.201100684] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2011] [Revised: 09/30/2011] [Accepted: 10/27/2011] [Indexed: 11/11/2022]
Abstract
Therapeutic monoclonal antibodies (mAbs), immunoglobulins, have been efficiently used in the treatment of many diseases, such as cancer, inflammatory and cardiovascular diseases, and organ transplantation. mAbs are glycoprotein molecules undergoing posttranslational modifications. Glycosylation is one of the posttranslational modifications. Different glycoforms that are important for maintaining the potency of mAb drugs show various biological activities. Therefore, the profile of the glycans and glycosylation sites should be determined to produce safe, good quality, consistent mAb drugs for human use. For this reason, simple, robust, accurate, and reproducible analytical methods need to be developed. In this article, chromatographic methods for the analysis of the glycoforms on the glycosylation site and the glycans in mAb biopharmaceuticals have been evaluated.
Collapse
Affiliation(s)
- Ebru Uçaktürk
- Hacettepe University, Faculty of Pharmacy, Department of Basic Pharmaceutical Science, Ankara, Turkey.
| |
Collapse
|
41
|
Ijiri S, Todoroki K, Yoshida H, Yoshitake T, Nohta H, Yamaguchi M. Highly sensitive capillary electrophoresis analysis of N-linked oligosaccharides in glycoproteins following fluorescence derivatization with rhodamine 110 and laser-induced fluorescence detection. Electrophoresis 2011; 32:3499-509. [DOI: 10.1002/elps.201100258] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
42
|
Nebija D, Kopelent-Frank H, Urban E, Noe CR, Lachmann B. Comparison of two-dimensional gel electrophoresis patterns and MALDI-TOF MS analysis of therapeutic recombinant monoclonal antibodies trastuzumab and rituximab. J Pharm Biomed Anal 2011; 56:684-91. [DOI: 10.1016/j.jpba.2011.07.006] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2011] [Revised: 05/25/2011] [Accepted: 07/06/2011] [Indexed: 01/14/2023]
|
43
|
Mechref Y. Analysis of glycans derived from glycoconjugates by capillary electrophoresis-mass spectrometry. Electrophoresis 2011; 32:3467-81. [PMID: 22180203 PMCID: PMC3360420 DOI: 10.1002/elps.201100342] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
The high structural variation of glycan derived from glycoconjugates, which substantially increases with the molecular size of a protein, contributes to the complexity of glycosylation patterns commonly associated with glycoconjugates. In the case of glycoproteins, such variation originates from the multiple glycosylation sites of proteins and the number of glycan structures associated with each site (microheterogeneity). The ability to comprehensively characterize highly complex mixture of glycans has been analytically stimulating and challenging. Although the most powerful MS and MS/MS techniques are capable of providing a wealth of structural information, they are still not able to readily identify isomeric glycan structures without high-order MS/MS (MS(n) ). The analysis of isomeric glycan structures has been attained using several separation methods, including high-pH anion-exchange chromatography, hydrophilic interaction chromatography and GC. However, CE and microfluidics CE (MCE) offer high separation efficiency and resolutions, allowing the separation of closely related glycan structures. Therefore, interfacing CE and MCE to MS is a powerful analytical approach, allowing potentially comprehensive and sensitive analysis of complex glycan samples. This review describes and discusses the utility of different CE and MCE approaches in the structural characterization of glycoproteins and the feasibility of interfacing these approaches to MS.
Collapse
Affiliation(s)
- Yehia Mechref
- Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409-1061, USA.
| |
Collapse
|
44
|
Yagi Y, Yamamoto S, Kakehi K, Hayakawa T, Ohyama Y, Suzuki S. Application of partial-filling capillary electrophoresis using lectins and glycosidases for the characterization of oligosaccharides in a therapeutic antibody. Electrophoresis 2011; 32:2979-85. [DOI: 10.1002/elps.201100126] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
45
|
Ha S, Wang Y, Rustandi RR. Biochemical and biophysical characterization of humanized IgG1 produced in Pichia pastoris. MAbs 2011; 3:453-60. [PMID: 22048694 DOI: 10.4161/mabs.3.5.16891] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
The first full length IgG produced in Pichia pastoris was reported in late 1980. However, use of a wild-type Pichia expression system to produce IgGs with human-like N-linked glycans was not possible until recently. Advances in glycoengineering have enabled organisms such as Pichia to mimic human N-glycan biosynthesis and produce IgGs with human glycans on an industrial scale. Since there are only a few reports of the analytical characterization of Pichia-produced IgG, we summarize the results known in this field, and provide additional characterization data generated in our laboratories. The data suggest that Pichia-produced IgG has the same stability as that produced in Chinese hamster ovary (CHO) cells. It has similar aggregation profiles, charge variant distribution and oxidation levels as those for a CHO IgG. It contains human N-linked glycans and O-linked single mannose. Because of the comparable biophysical and biochemical characteristics, glycoengineered Pichia pastoris is an attractive expression system for therapeutic IgG productions.
Collapse
Affiliation(s)
- Sha Ha
- Department of Bioprocess Analytical and Formulation Sciences, Merck Research Laboratories, West Point, PA, USA
| | | | | |
Collapse
|
46
|
Zhang T, Bourret J, Cano T. Isolation and characterization of therapeutic antibody charge variants using cation exchange displacement chromatography. J Chromatogr A 2011; 1218:5079-86. [DOI: 10.1016/j.chroma.2011.05.061] [Citation(s) in RCA: 55] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2010] [Revised: 03/02/2011] [Accepted: 05/17/2011] [Indexed: 10/18/2022]
|
47
|
Mittermayr S, Bones J, Doherty M, Guttman A, Rudd PM. Multiplexed analytical glycomics: rapid and confident IgG N-glycan structural elucidation. J Proteome Res 2011; 10:3820-9. [PMID: 21699237 DOI: 10.1021/pr200371s] [Citation(s) in RCA: 60] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
N-glycans attached to the C(H)2 domains of the Fc or the antigen binding regions of IgG play an important role in stabilizing and modulating antibody activity. Exhaustive elucidation of 32 IgG N-glycans using a combination of weak anion exchange enrichment and exoglycosidase array digestion with subsequent profiling exceeded 48 h. Pursuing increased throughput and associated structural annotation confidence, we compared the 1.7 μm hydrophilic interaction phase for UPLC with CE-LIF for the rapid and comprehensive characterization of N-glycans released from healthy human serum polyclonal IgG. Combination of the data individually generated using each technique demonstrated that complete structural annotation was possible within a total analysis time of 20 min due to the advantageous orthogonality of the separation mechanisms. The parallel use of both analytical techniques provides a powerful platform for rapid and comprehensive analysis of IgG N-glycosylation present on therapeutic antibodies or on antibodies of biomedical or pathological significance.
Collapse
Affiliation(s)
- Stefan Mittermayr
- NIBRT Dublin-Oxford Glycobiology Laboratory, NIBRT - The National Institute for Bioprocessing Research and Training, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland
| | | | | | | | | |
Collapse
|
48
|
De Santis R, Anastasi AM, Pelliccia A, Rosi A, Albertoni C, Verdoliva A, Petronzelli F, D'Alessio V, Serani S, Nuzzolo CA. Chemical linkage to injected tissues is a distinctive property of oxidized avidin. PLoS One 2011; 6:e21075. [PMID: 21701578 PMCID: PMC3118792 DOI: 10.1371/journal.pone.0021075] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2011] [Accepted: 05/18/2011] [Indexed: 12/25/2022] Open
Abstract
We recently reported that the oxidized avidin, named AvidinOX®, resides for weeks within injected tissues as a consequence of the formation of Schiff's bases between its aldehyde groups and tissue protein amino groups. We also showed, in a mouse pre-clinical model, the usefulness of AvidinOX for the delivery of radiolabeled biotin to inoperable tumors. Taking into account that AvidinOX is the first oxidized glycoprotein known to chemically link to injected tissues, we tested in the mouse a panel of additional oxidized glycoproteins, with the aim of investigating the phenomenon. We produced oxidized ovalbumin and mannosylated streptavidin which share with avidin glycosylation pattern and tetrameric structure, respectively and found that neither of them linked significantly to cells in vitro nor to injected tissues in vivo, despite the presence of functional aldehyde groups. The study, extended to additional oxidized glycoproteins, showed that the in vivo chemical conjugation is a distinctive property of the oxidized avidin. Relevance of the high cationic charge of avidin into the stable linkage of AvidinOX to tissues is demonstrated as the oxidized acetylated avidin lost the property. Plasmon resonance on matrix proteins and cellular impedance analyses showed in vitro that avidin exhibits a peculiar interaction with proteins and cells that allows the formation of highly stable Schiff's bases, after oxidation.
Collapse
Affiliation(s)
- Rita De Santis
- Department of Immunology, Sigma-Tau SpA, Pomezia, Rome, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Pacis E, Yu M, Autsen J, Bayer R, Li F. Effects of cell culture conditions on antibody N-linked glycosylation-what affects high mannose 5 glycoform. Biotechnol Bioeng 2011; 108:2348-58. [DOI: 10.1002/bit.23200] [Citation(s) in RCA: 130] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2011] [Revised: 03/28/2011] [Accepted: 04/25/2011] [Indexed: 01/18/2023]
|
50
|
del Val IJ, Kontoravdi C, Nagy JM. Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns. Biotechnol Prog 2010; 26:1505-27. [DOI: 10.1002/btpr.470] [Citation(s) in RCA: 107] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
|